nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—CYP2C8—Bupropion—obesity	0.0368	0.0986	CbGbCtD
Pazopanib—CYP1A2—Phentermine—obesity	0.0335	0.0898	CbGbCtD
Pazopanib—CYP1A2—Phenylpropanolamine—obesity	0.032	0.0856	CbGbCtD
Pazopanib—CYP1A2—Bupropion—obesity	0.0285	0.0763	CbGbCtD
Pazopanib—CYP2D6—Phentermine—obesity	0.0276	0.074	CbGbCtD
Pazopanib—CYP2C8—Cimetidine—obesity	0.027	0.0724	CbGbCtD
Pazopanib—CYP2D6—Bupropion—obesity	0.0235	0.0629	CbGbCtD
Pazopanib—CYP3A4—Sibutramine—obesity	0.0232	0.062	CbGbCtD
Pazopanib—CYP2D6—Methamphetamine—obesity	0.0221	0.0591	CbGbCtD
Pazopanib—CYP1A2—Cimetidine—obesity	0.0209	0.056	CbGbCtD
Pazopanib—ABCB1—Cimetidine—obesity	0.0183	0.049	CbGbCtD
Pazopanib—CYP3A4—Benzphetamine—obesity	0.0176	0.047	CbGbCtD
Pazopanib—CYP2D6—Cimetidine—obesity	0.0172	0.0462	CbGbCtD
Pazopanib—CYP3A4—Bupropion—obesity	0.0149	0.04	CbGbCtD
Pazopanib—CYP3A4—Orlistat—obesity	0.0122	0.0326	CbGbCtD
Pazopanib—CYP3A4—Cimetidine—obesity	0.011	0.0293	CbGbCtD
Pazopanib—BMPR1B—ovarian follicle—obesity	0.01	0.0643	CbGeAlD
Pazopanib—CYP3A4—Topiramate—obesity	0.00718	0.0192	CbGbCtD
Pazopanib—Rilpivirine—NR1I2—obesity	0.00498	1	CrCbGaD
Pazopanib—MAP3K9—islet of Langerhans—obesity	0.0024	0.0154	CbGeAlD
Pazopanib—TAOK1—respiratory system—obesity	0.0017	0.0109	CbGeAlD
Pazopanib—SH2B3—islet of Langerhans—obesity	0.00169	0.0109	CbGeAlD
Pazopanib—FGF1—hindbrain—obesity	0.00152	0.00974	CbGeAlD
Pazopanib—STK16—islet of Langerhans—obesity	0.00144	0.00923	CbGeAlD
Pazopanib—PLK4—respiratory system—obesity	0.00144	0.00923	CbGeAlD
Pazopanib—MAP3K9—digestive system—obesity	0.00144	0.00922	CbGeAlD
Pazopanib—FGFR2—hindbrain—obesity	0.00143	0.0092	CbGeAlD
Pazopanib—MAP3K9—adrenal gland—obesity	0.00137	0.00879	CbGeAlD
Pazopanib—SH2B3—adrenal cortex—obesity	0.00134	0.00861	CbGeAlD
Pazopanib—FGFR3—respiratory system—obesity	0.00134	0.00858	CbGeAlD
Pazopanib—MAP3K19—respiratory system—obesity	0.00132	0.0085	CbGeAlD
Pazopanib—ITK—adipose tissue—obesity	0.00126	0.00808	CbGeAlD
Pazopanib—TAOK3—hindbrain—obesity	0.00125	0.00804	CbGeAlD
Pazopanib—PI4KB—islet of Langerhans—obesity	0.00125	0.00804	CbGeAlD
Pazopanib—PDGFRA—gall bladder—obesity	0.00123	0.00788	CbGeAlD
Pazopanib—SH2B3—cardiovascular system—obesity	0.00122	0.00785	CbGeAlD
Pazopanib—PI4KB—respiratory system—obesity	0.00118	0.00759	CbGeAlD
Pazopanib—LIMK2—respiratory system—obesity	0.00116	0.00745	CbGeAlD
Pazopanib—TAOK1—pituitary gland—obesity	0.00115	0.00739	CbGeAlD
Pazopanib—TAOK1—adipose tissue—obesity	0.00115	0.00736	CbGeAlD
Pazopanib—ITK—adrenal gland—obesity	0.00113	0.00725	CbGeAlD
Pazopanib—MAP2K5—hindbrain—obesity	0.00112	0.00721	CbGeAlD
Pazopanib—PIP4K2C—islet of Langerhans—obesity	0.0011	0.00705	CbGeAlD
Pazopanib—SH2B3—pituitary gland—obesity	0.00108	0.00695	CbGeAlD
Pazopanib—SH2B3—adipose tissue—obesity	0.00108	0.00693	CbGeAlD
Pazopanib—MAP3K9—liver—obesity	0.00107	0.00687	CbGeAlD
Pazopanib—FLT4—respiratory system—obesity	0.00104	0.0067	CbGeAlD
Pazopanib—TAOK1—adrenal gland—obesity	0.00103	0.0066	CbGeAlD
Pazopanib—STK36—adrenal cortex—obesity	0.00101	0.00647	CbGeAlD
Pazopanib—KIT—hindbrain—obesity	0.000996	0.00639	CbGeAlD
Pazopanib—PI4KB—adrenal cortex—obesity	0.000993	0.00637	CbGeAlD
Pazopanib—KIT—gall bladder—obesity	0.000983	0.0063	CbGeAlD
Pazopanib—ITK—endocrine gland—obesity	0.00098	0.00629	CbGeAlD
Pazopanib—SH2B3—adrenal gland—obesity	0.000968	0.00621	CbGeAlD
Pazopanib—PDGFRB—gall bladder—obesity	0.00096	0.00616	CbGeAlD
Pazopanib—AURKC—adrenal gland—obesity	0.000953	0.00612	CbGeAlD
Pazopanib—FGF1—respiratory system—obesity	0.000928	0.00595	CbGeAlD
Pazopanib—STK16—pituitary gland—obesity	0.000922	0.00591	CbGeAlD
Pazopanib—STK16—adipose tissue—obesity	0.000918	0.00589	CbGeAlD
Pazopanib—RIOK2—pituitary gland—obesity	0.000907	0.00582	CbGeAlD
Pazopanib—RIOK2—adipose tissue—obesity	0.000904	0.0058	CbGeAlD
Pazopanib—BMPR1B—adipose tissue—obesity	0.000895	0.00574	CbGeAlD
Pazopanib—TAOK1—endocrine gland—obesity	0.000892	0.00572	CbGeAlD
Pazopanib—FLT4—adrenal cortex—obesity	0.000876	0.00562	CbGeAlD
Pazopanib—FGFR2—respiratory system—obesity	0.000876	0.00562	CbGeAlD
Pazopanib—PLK4—adrenal gland—obesity	0.000872	0.00559	CbGeAlD
Pazopanib—PIP4K2C—adrenal cortex—obesity	0.000872	0.00559	CbGeAlD
Pazopanib—STK16—digestive system—obesity	0.000864	0.00554	CbGeAlD
Pazopanib—FLT1—islet of Langerhans—obesity	0.00086	0.00552	CbGeAlD
Pazopanib—EPHB6—islet of Langerhans—obesity	0.00085	0.00545	CbGeAlD
Pazopanib—AURKC—endocrine gland—obesity	0.000827	0.0053	CbGeAlD
Pazopanib—STK16—adrenal gland—obesity	0.000823	0.00528	CbGeAlD
Pazopanib—STK36—pituitary gland—obesity	0.000815	0.00523	CbGeAlD
Pazopanib—FLT1—respiratory system—obesity	0.000812	0.00521	CbGeAlD
Pazopanib—STK36—adipose tissue—obesity	0.000812	0.00521	CbGeAlD
Pazopanib—TAOK3—islet of Langerhans—obesity	0.000811	0.0052	CbGeAlD
Pazopanib—FGFR3—adrenal gland—obesity	0.000811	0.0052	CbGeAlD
Pazopanib—RIOK2—adrenal gland—obesity	0.000811	0.0052	CbGeAlD
Pazopanib—TAOK1—liver—obesity	0.000804	0.00516	CbGeAlD
Pazopanib—PI4KB—pituitary gland—obesity	0.000803	0.00515	CbGeAlD
Pazopanib—BMPR1B—adrenal gland—obesity	0.000803	0.00515	CbGeAlD
Pazopanib—FLT4—cardiovascular system—obesity	0.0008	0.00513	CbGeAlD
Pazopanib—PI4KB—adipose tissue—obesity	0.000799	0.00513	CbGeAlD
Pazopanib—LIMK2—pituitary gland—obesity	0.000788	0.00505	CbGeAlD
Pazopanib—LIMK2—adipose tissue—obesity	0.000785	0.00503	CbGeAlD
Pazopanib—STK10—respiratory system—obesity	0.000769	0.00493	CbGeAlD
Pazopanib—TAOK3—respiratory system—obesity	0.000766	0.00491	CbGeAlD
Pazopanib—PDGFRA—respiratory system—obesity	0.000761	0.00488	CbGeAlD
Pazopanib—SH2B3—liver—obesity	0.000757	0.00486	CbGeAlD
Pazopanib—PLK4—endocrine gland—obesity	0.000756	0.00485	CbGeAlD
Pazopanib—STK36—adrenal gland—obesity	0.000728	0.00467	CbGeAlD
Pazopanib—PI4KB—adrenal gland—obesity	0.000717	0.0046	CbGeAlD
Pazopanib—STK16—endocrine gland—obesity	0.000714	0.00458	CbGeAlD
Pazopanib—FGF1—cardiovascular system—obesity	0.00071	0.00456	CbGeAlD
Pazopanib—LYN—endocrine gland—obesity	0.000707	0.00453	CbGeAlD
Pazopanib—FLT4—adipose tissue—obesity	0.000705	0.00452	CbGeAlD
Pazopanib—PIP4K2C—pituitary gland—obesity	0.000704	0.00452	CbGeAlD
Pazopanib—LIMK2—adrenal gland—obesity	0.000704	0.00452	CbGeAlD
Pazopanib—FGFR3—endocrine gland—obesity	0.000703	0.00451	CbGeAlD
Pazopanib—PIP4K2C—adipose tissue—obesity	0.000701	0.0045	CbGeAlD
Pazopanib—FGFR1—pituitary gland—obesity	0.000699	0.00448	CbGeAlD
Pazopanib—BMPR1B—endocrine gland—obesity	0.000696	0.00446	CbGeAlD
Pazopanib—FGFR1—adipose tissue—obesity	0.000696	0.00446	CbGeAlD
Pazopanib—KDR—respiratory system—obesity	0.000686	0.0044	CbGeAlD
Pazopanib—FLT1—adrenal cortex—obesity	0.000681	0.00437	CbGeAlD
Pazopanib—FGFR2—cardiovascular system—obesity	0.000671	0.0043	CbGeAlD
Pazopanib—CSF1R—respiratory system—obesity	0.00067	0.0043	CbGeAlD
Pazopanib—MAP3K2—adipose tissue—obesity	0.000665	0.00426	CbGeAlD
Pazopanib—STK16—liver—obesity	0.000644	0.00413	CbGeAlD
Pazopanib—TAOK3—adrenal cortex—obesity	0.000643	0.00412	CbGeAlD
Pazopanib—LYN—liver—obesity	0.000637	0.00409	CbGeAlD
Pazopanib—FGFR3—liver—obesity	0.000634	0.00407	CbGeAlD
Pazopanib—RIOK2—liver—obesity	0.000634	0.00407	CbGeAlD
Pazopanib—FLT4—adrenal gland—obesity	0.000633	0.00406	CbGeAlD
Pazopanib—STK36—endocrine gland—obesity	0.000631	0.00405	CbGeAlD
Pazopanib—PIP4K2C—adrenal gland—obesity	0.000629	0.00404	CbGeAlD
Pazopanib—PDGFRB—islet of Langerhans—obesity	0.000629	0.00404	CbGeAlD
Pazopanib—FGF1—pituitary gland—obesity	0.000629	0.00403	CbGeAlD
Pazopanib—FGF1—adipose tissue—obesity	0.000626	0.00402	CbGeAlD
Pazopanib—FGFR1—adrenal gland—obesity	0.000624	0.004	CbGeAlD
Pazopanib—LCK—adipose tissue—obesity	0.000623	0.00399	CbGeAlD
Pazopanib—FLT1—cardiovascular system—obesity	0.000622	0.00399	CbGeAlD
Pazopanib—PI4KB—endocrine gland—obesity	0.000622	0.00399	CbGeAlD
Pazopanib—LIMK2—endocrine gland—obesity	0.00061	0.00392	CbGeAlD
Pazopanib—KIT—respiratory system—obesity	0.000608	0.0039	CbGeAlD
Pazopanib—MAP3K2—adrenal gland—obesity	0.000596	0.00383	CbGeAlD
Pazopanib—PDGFRB—respiratory system—obesity	0.000594	0.00381	CbGeAlD
Pazopanib—FGFR2—adipose tissue—obesity	0.000592	0.00379	CbGeAlD
Pazopanib—FGF1—digestive system—obesity	0.00059	0.00378	CbGeAlD
Pazopanib—STK10—cardiovascular system—obesity	0.000589	0.00378	CbGeAlD
Pazopanib—TAOK3—cardiovascular system—obesity	0.000586	0.00376	CbGeAlD
Pazopanib—PDGFRA—cardiovascular system—obesity	0.000583	0.00374	CbGeAlD
Pazopanib—KDR—adrenal cortex—obesity	0.000576	0.00369	CbGeAlD
Pazopanib—MAP2K5—adrenal cortex—obesity	0.000576	0.00369	CbGeAlD
Pazopanib—STK36—liver—obesity	0.000569	0.00365	CbGeAlD
Pazopanib—CSF1R—adrenal cortex—obesity	0.000562	0.00361	CbGeAlD
Pazopanib—FGF1—adrenal gland—obesity	0.000562	0.0036	CbGeAlD
Pazopanib—PI4KB—liver—obesity	0.000561	0.0036	CbGeAlD
Pazopanib—LCK—adrenal gland—obesity	0.000558	0.00358	CbGeAlD
Pazopanib—FGFR2—digestive system—obesity	0.000557	0.00357	CbGeAlD
Pazopanib—FLT1—pituitary gland—obesity	0.000551	0.00353	CbGeAlD
Pazopanib—LIMK2—liver—obesity	0.00055	0.00353	CbGeAlD
Pazopanib—FLT4—endocrine gland—obesity	0.000549	0.00352	CbGeAlD
Pazopanib—FLT1—adipose tissue—obesity	0.000548	0.00352	CbGeAlD
Pazopanib—PIP4K2C—endocrine gland—obesity	0.000546	0.0035	CbGeAlD
Pazopanib—EPHB6—pituitary gland—obesity	0.000544	0.00349	CbGeAlD
Pazopanib—EPHB6—adipose tissue—obesity	0.000542	0.00348	CbGeAlD
Pazopanib—FGFR2—adrenal gland—obesity	0.000531	0.0034	CbGeAlD
Pazopanib—KDR—cardiovascular system—obesity	0.000526	0.00337	CbGeAlD
Pazopanib—MAP2K5—cardiovascular system—obesity	0.000526	0.00337	CbGeAlD
Pazopanib—TAOK3—pituitary gland—obesity	0.000519	0.00333	CbGeAlD
Pazopanib—STK10—adipose tissue—obesity	0.000519	0.00333	CbGeAlD
Pazopanib—MAP3K2—endocrine gland—obesity	0.000517	0.00332	CbGeAlD
Pazopanib—TAOK3—adipose tissue—obesity	0.000517	0.00332	CbGeAlD
Pazopanib—FLT1—digestive system—obesity	0.000516	0.00331	CbGeAlD
Pazopanib—PDGFRA—adipose tissue—obesity	0.000514	0.0033	CbGeAlD
Pazopanib—CSF1R—cardiovascular system—obesity	0.000513	0.00329	CbGeAlD
Pazopanib—PDGFRB—adrenal cortex—obesity	0.000499	0.0032	CbGeAlD
Pazopanib—FLT4—liver—obesity	0.000495	0.00317	CbGeAlD
Pazopanib—PIP4K2C—liver—obesity	0.000492	0.00316	CbGeAlD
Pazopanib—FLT1—adrenal gland—obesity	0.000492	0.00315	CbGeAlD
Pazopanib—STK10—digestive system—obesity	0.000489	0.00313	CbGeAlD
Pazopanib—FGFR1—liver—obesity	0.000488	0.00313	CbGeAlD
Pazopanib—FGF1—endocrine gland—obesity	0.000487	0.00313	CbGeAlD
Pazopanib—TAOK3—digestive system—obesity	0.000487	0.00312	CbGeAlD
Pazopanib—EPHB6—adrenal gland—obesity	0.000486	0.00312	CbGeAlD
Pazopanib—PDGFRA—digestive system—obesity	0.000484	0.0031	CbGeAlD
Pazopanib—MAP3K2—liver—obesity	0.000466	0.00299	CbGeAlD
Pazopanib—KIT—cardiovascular system—obesity	0.000466	0.00299	CbGeAlD
Pazopanib—STK10—adrenal gland—obesity	0.000466	0.00299	CbGeAlD
Pazopanib—KDR—pituitary gland—obesity	0.000465	0.00299	CbGeAlD
Pazopanib—MAP2K5—pituitary gland—obesity	0.000465	0.00299	CbGeAlD
Pazopanib—TAOK3—adrenal gland—obesity	0.000464	0.00298	CbGeAlD
Pazopanib—KDR—adipose tissue—obesity	0.000464	0.00297	CbGeAlD
Pazopanib—MAP2K5—adipose tissue—obesity	0.000464	0.00297	CbGeAlD
Pazopanib—UGT1A1—digestive system—obesity	0.000461	0.00296	CbGeAlD
Pazopanib—PDGFRA—adrenal gland—obesity	0.000461	0.00296	CbGeAlD
Pazopanib—FGFR2—endocrine gland—obesity	0.00046	0.00295	CbGeAlD
Pazopanib—PDGFRB—cardiovascular system—obesity	0.000455	0.00292	CbGeAlD
Pazopanib—CSF1R—pituitary gland—obesity	0.000454	0.00291	CbGeAlD
Pazopanib—CSF1R—adipose tissue—obesity	0.000452	0.0029	CbGeAlD
Pazopanib—FGF1—liver—obesity	0.000439	0.00282	CbGeAlD
Pazopanib—LCK—liver—obesity	0.000437	0.0028	CbGeAlD
Pazopanib—KDR—digestive system—obesity	0.000436	0.0028	CbGeAlD
Pazopanib—FLT1—endocrine gland—obesity	0.000427	0.00274	CbGeAlD
Pazopanib—CSF1R—digestive system—obesity	0.000426	0.00273	CbGeAlD
Pazopanib—KDR—adrenal gland—obesity	0.000416	0.00267	CbGeAlD
Pazopanib—MAP2K5—adrenal gland—obesity	0.000416	0.00267	CbGeAlD
Pazopanib—FGFR2—liver—obesity	0.000415	0.00266	CbGeAlD
Pazopanib—KIT—pituitary gland—obesity	0.000412	0.00265	CbGeAlD
Pazopanib—KIT—adipose tissue—obesity	0.000411	0.00263	CbGeAlD
Pazopanib—CSF1R—adrenal gland—obesity	0.000406	0.0026	CbGeAlD
Pazopanib—STK10—endocrine gland—obesity	0.000404	0.00259	CbGeAlD
Pazopanib—PDGFRB—pituitary gland—obesity	0.000403	0.00258	CbGeAlD
Pazopanib—TAOK3—endocrine gland—obesity	0.000402	0.00258	CbGeAlD
Pazopanib—PDGFRB—adipose tissue—obesity	0.000401	0.00257	CbGeAlD
Pazopanib—PDGFRA—endocrine gland—obesity	0.0004	0.00256	CbGeAlD
Pazopanib—KIT—digestive system—obesity	0.000387	0.00248	CbGeAlD
Pazopanib—FLT1—liver—obesity	0.000385	0.00247	CbGeAlD
Pazopanib—SLCO1B1—digestive system—obesity	0.000384	0.00246	CbGeAlD
Pazopanib—UGT1A1—endocrine gland—obesity	0.000381	0.00245	CbGeAlD
Pazopanib—PDGFRB—digestive system—obesity	0.000378	0.00242	CbGeAlD
Pazopanib—CYP2D6—hindbrain—obesity	0.000375	0.0024	CbGeAlD
Pazopanib—KIT—adrenal gland—obesity	0.000368	0.00236	CbGeAlD
Pazopanib—STK10—liver—obesity	0.000364	0.00233	CbGeAlD
Pazopanib—TAOK3—liver—obesity	0.000363	0.00233	CbGeAlD
Pazopanib—KDR—endocrine gland—obesity	0.000361	0.00231	CbGeAlD
Pazopanib—MAP2K5—endocrine gland—obesity	0.000361	0.00231	CbGeAlD
Pazopanib—PDGFRA—liver—obesity	0.00036	0.00231	CbGeAlD
Pazopanib—PDGFRB—adrenal gland—obesity	0.00036	0.00231	CbGeAlD
Pazopanib—CSF1R—endocrine gland—obesity	0.000352	0.00226	CbGeAlD
Pazopanib—UGT1A1—liver—obesity	0.000344	0.00221	CbGeAlD
Pazopanib—KDR—liver—obesity	0.000325	0.00209	CbGeAlD
Pazopanib—MAP2K5—liver—obesity	0.000325	0.00209	CbGeAlD
Pazopanib—CYP1A2—respiratory system—obesity	0.000321	0.00206	CbGeAlD
Pazopanib—KIT—endocrine gland—obesity	0.00032	0.00205	CbGeAlD
Pazopanib—SLCO1B1—endocrine gland—obesity	0.000317	0.00204	CbGeAlD
Pazopanib—CSF1R—liver—obesity	0.000317	0.00203	CbGeAlD
Pazopanib—Diarrhoea—Diethylpropion—obesity	0.000317	0.00157	CcSEcCtD
Pazopanib—Nausea—Phentermine—obesity	0.000316	0.00157	CcSEcCtD
Pazopanib—Asthenia—Cimetidine—obesity	0.000316	0.00157	CcSEcCtD
Pazopanib—Myocardial infarction—Bupropion—obesity	0.000315	0.00157	CcSEcCtD
Pazopanib—Stomatitis—Bupropion—obesity	0.000314	0.00156	CcSEcCtD
Pazopanib—Jaundice—Bupropion—obesity	0.000314	0.00156	CcSEcCtD
Pazopanib—PDGFRB—endocrine gland—obesity	0.000312	0.002	CbGeAlD
Pazopanib—Eye disorder—Sibutramine—obesity	0.00031	0.00154	CcSEcCtD
Pazopanib—Mediastinal disorder—Orlistat—obesity	0.000309	0.00153	CcSEcCtD
Pazopanib—Dizziness—Diethylpropion—obesity	0.000306	0.00152	CcSEcCtD
Pazopanib—Blood alkaline phosphatase increased—Topiramate—obesity	0.000306	0.00152	CcSEcCtD
Pazopanib—Epistaxis—Bupropion—obesity	0.000303	0.00151	CcSEcCtD
Pazopanib—Alopecia—Orlistat—obesity	0.000303	0.0015	CcSEcCtD
Pazopanib—Diarrhoea—Cimetidine—obesity	0.000301	0.0015	CcSEcCtD
Pazopanib—Angiopathy—Sibutramine—obesity	0.000301	0.00149	CcSEcCtD
Pazopanib—Mental disorder—Orlistat—obesity	0.0003	0.00149	CcSEcCtD
Pazopanib—Malnutrition—Orlistat—obesity	0.000298	0.00148	CcSEcCtD
Pazopanib—Chills—Sibutramine—obesity	0.000297	0.00148	CcSEcCtD
Pazopanib—Hepatic failure—Topiramate—obesity	0.000296	0.00147	CcSEcCtD
Pazopanib—Vomiting—Diethylpropion—obesity	0.000294	0.00146	CcSEcCtD
Pazopanib—Flatulence—Orlistat—obesity	0.000294	0.00146	CcSEcCtD
Pazopanib—Alopecia—Sibutramine—obesity	0.000293	0.00145	CcSEcCtD
Pazopanib—Rash—Diethylpropion—obesity	0.000292	0.00145	CcSEcCtD
Pazopanib—Dysgeusia—Orlistat—obesity	0.000292	0.00145	CcSEcCtD
Pazopanib—Dermatitis—Diethylpropion—obesity	0.000292	0.00145	CcSEcCtD
Pazopanib—Dizziness—Cimetidine—obesity	0.000291	0.00145	CcSEcCtD
Pazopanib—Haemoglobin—Bupropion—obesity	0.00029	0.00144	CcSEcCtD
Pazopanib—Headache—Diethylpropion—obesity	0.00029	0.00144	CcSEcCtD
Pazopanib—Haemorrhage—Bupropion—obesity	0.000289	0.00143	CcSEcCtD
Pazopanib—Malnutrition—Sibutramine—obesity	0.000288	0.00143	CcSEcCtD
Pazopanib—KIT—liver—obesity	0.000288	0.00185	CbGeAlD
Pazopanib—Hypoaesthesia—Bupropion—obesity	0.000287	0.00143	CcSEcCtD
Pazopanib—Muscle spasms—Orlistat—obesity	0.000287	0.00142	CcSEcCtD
Pazopanib—SLCO1B1—liver—obesity	0.000286	0.00183	CbGeAlD
Pazopanib—Urinary tract disorder—Bupropion—obesity	0.000285	0.00142	CcSEcCtD
Pazopanib—Oedema peripheral—Bupropion—obesity	0.000285	0.00141	CcSEcCtD
Pazopanib—Hot flush—Topiramate—obesity	0.000284	0.00141	CcSEcCtD
Pazopanib—Flatulence—Sibutramine—obesity	0.000284	0.00141	CcSEcCtD
Pazopanib—Connective tissue disorder—Bupropion—obesity	0.000284	0.00141	CcSEcCtD
Pazopanib—Urethral disorder—Bupropion—obesity	0.000283	0.00141	CcSEcCtD
Pazopanib—Dysgeusia—Sibutramine—obesity	0.000282	0.0014	CcSEcCtD
Pazopanib—Menopausal symptoms—Topiramate—obesity	0.000282	0.0014	CcSEcCtD
Pazopanib—PDGFRB—liver—obesity	0.000281	0.0018	CbGeAlD
Pazopanib—Vision blurred—Orlistat—obesity	0.000281	0.0014	CcSEcCtD
Pazopanib—ABCG2—adrenal cortex—obesity	0.00028	0.0018	CbGeAlD
Pazopanib—Vomiting—Cimetidine—obesity	0.00028	0.00139	CcSEcCtD
Pazopanib—Rash—Cimetidine—obesity	0.000278	0.00138	CcSEcCtD
Pazopanib—Dermatitis—Cimetidine—obesity	0.000278	0.00138	CcSEcCtD
Pazopanib—Muscle spasms—Sibutramine—obesity	0.000277	0.00138	CcSEcCtD
Pazopanib—Headache—Cimetidine—obesity	0.000276	0.00137	CcSEcCtD
Pazopanib—Nausea—Diethylpropion—obesity	0.000275	0.00137	CcSEcCtD
Pazopanib—Vision blurred—Sibutramine—obesity	0.000272	0.00135	CcSEcCtD
Pazopanib—Lethargy—Topiramate—obesity	0.000271	0.00135	CcSEcCtD
Pazopanib—Eye disorder—Bupropion—obesity	0.00027	0.00134	CcSEcCtD
Pazopanib—Cardiac disorder—Bupropion—obesity	0.000268	0.00133	CcSEcCtD
Pazopanib—Flushing—Bupropion—obesity	0.000268	0.00133	CcSEcCtD
Pazopanib—Hyponatraemia—Topiramate—obesity	0.000267	0.00133	CcSEcCtD
Pazopanib—Anaemia—Sibutramine—obesity	0.000267	0.00132	CcSEcCtD
Pazopanib—Angiopathy—Bupropion—obesity	0.000262	0.0013	CcSEcCtD
Pazopanib—Nausea—Cimetidine—obesity	0.000262	0.0013	CcSEcCtD
Pazopanib—Mediastinal disorder—Bupropion—obesity	0.00026	0.00129	CcSEcCtD
Pazopanib—Cough—Orlistat—obesity	0.00026	0.00129	CcSEcCtD
Pazopanib—Chills—Bupropion—obesity	0.000259	0.00129	CcSEcCtD
Pazopanib—Syncope—Sibutramine—obesity	0.000259	0.00128	CcSEcCtD
Pazopanib—Leukopenia—Sibutramine—obesity	0.000258	0.00128	CcSEcCtD
Pazopanib—Face oedema—Topiramate—obesity	0.000257	0.00128	CcSEcCtD
Pazopanib—Alopecia—Bupropion—obesity	0.000255	0.00127	CcSEcCtD
Pazopanib—Myalgia—Orlistat—obesity	0.000254	0.00126	CcSEcCtD
Pazopanib—Chest pain—Orlistat—obesity	0.000254	0.00126	CcSEcCtD
Pazopanib—Loss of consciousness—Sibutramine—obesity	0.000254	0.00126	CcSEcCtD
Pazopanib—Mental disorder—Bupropion—obesity	0.000253	0.00126	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000252	0.00125	CcSEcCtD
Pazopanib—Cough—Sibutramine—obesity	0.000252	0.00125	CcSEcCtD
Pazopanib—Malnutrition—Bupropion—obesity	0.000251	0.00125	CcSEcCtD
Pazopanib—Blood creatinine increased—Topiramate—obesity	0.000249	0.00124	CcSEcCtD
Pazopanib—Hypertension—Sibutramine—obesity	0.000249	0.00124	CcSEcCtD
Pazopanib—Dry mouth—Orlistat—obesity	0.000248	0.00123	CcSEcCtD
Pazopanib—Flatulence—Bupropion—obesity	0.000248	0.00123	CcSEcCtD
Pazopanib—Dehydration—Topiramate—obesity	0.000247	0.00123	CcSEcCtD
Pazopanib—Dysgeusia—Bupropion—obesity	0.000246	0.00122	CcSEcCtD
Pazopanib—Liver function test abnormal—Topiramate—obesity	0.000246	0.00122	CcSEcCtD
Pazopanib—Myalgia—Sibutramine—obesity	0.000246	0.00122	CcSEcCtD
Pazopanib—Arthralgia—Sibutramine—obesity	0.000246	0.00122	CcSEcCtD
Pazopanib—Chest pain—Sibutramine—obesity	0.000246	0.00122	CcSEcCtD
Pazopanib—Oedema—Orlistat—obesity	0.000243	0.00121	CcSEcCtD
Pazopanib—Abdominal pain upper—Topiramate—obesity	0.000243	0.00121	CcSEcCtD
Pazopanib—Muscle spasms—Bupropion—obesity	0.000242	0.0012	CcSEcCtD
Pazopanib—Infection—Orlistat—obesity	0.000242	0.0012	CcSEcCtD
Pazopanib—Breast disorder—Topiramate—obesity	0.00024	0.00119	CcSEcCtD
Pazopanib—Dry mouth—Sibutramine—obesity	0.00024	0.00119	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Topiramate—obesity	0.00024	0.00119	CcSEcCtD
Pazopanib—Nervous system disorder—Orlistat—obesity	0.000239	0.00118	CcSEcCtD
Pazopanib—Nasopharyngitis—Topiramate—obesity	0.000238	0.00118	CcSEcCtD
Pazopanib—Vision blurred—Bupropion—obesity	0.000237	0.00118	CcSEcCtD
Pazopanib—Skin disorder—Orlistat—obesity	0.000236	0.00117	CcSEcCtD
Pazopanib—Oedema—Sibutramine—obesity	0.000235	0.00117	CcSEcCtD
Pazopanib—Hyperhidrosis—Orlistat—obesity	0.000235	0.00117	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Topiramate—obesity	0.000235	0.00117	CcSEcCtD
Pazopanib—Infection—Sibutramine—obesity	0.000234	0.00116	CcSEcCtD
Pazopanib—CYP2C8—pituitary gland—obesity	0.000233	0.00149	CbGeAlD
Pazopanib—Anaemia—Bupropion—obesity	0.000232	0.00115	CcSEcCtD
Pazopanib—Shock—Sibutramine—obesity	0.000232	0.00115	CcSEcCtD
Pazopanib—Abdominal distension—Topiramate—obesity	0.000231	0.00115	CcSEcCtD
Pazopanib—Thrombocytopenia—Sibutramine—obesity	0.00023	0.00114	CcSEcCtD
Pazopanib—Skin disorder—Sibutramine—obesity	0.000229	0.00114	CcSEcCtD
Pazopanib—Hyperhidrosis—Sibutramine—obesity	0.000228	0.00113	CcSEcCtD
Pazopanib—ABCG2—pituitary gland—obesity	0.000226	0.00145	CbGeAlD
Pazopanib—ABCG2—adipose tissue—obesity	0.000226	0.00145	CbGeAlD
Pazopanib—Syncope—Bupropion—obesity	0.000225	0.00112	CcSEcCtD
Pazopanib—Pancreatitis—Topiramate—obesity	0.000225	0.00112	CcSEcCtD
Pazopanib—Leukopenia—Bupropion—obesity	0.000225	0.00112	CcSEcCtD
Pazopanib—Anorexia—Sibutramine—obesity	0.000224	0.00111	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Orlistat—obesity	0.000222	0.0011	CcSEcCtD
Pazopanib—Loss of consciousness—Bupropion—obesity	0.000221	0.0011	CcSEcCtD
Pazopanib—Insomnia—Orlistat—obesity	0.00022	0.00109	CcSEcCtD
Pazopanib—Cough—Bupropion—obesity	0.000219	0.00109	CcSEcCtD
Pazopanib—Paraesthesia—Orlistat—obesity	0.000218	0.00108	CcSEcCtD
Pazopanib—Hypertension—Bupropion—obesity	0.000217	0.00108	CcSEcCtD
Pazopanib—Neutropenia—Topiramate—obesity	0.000215	0.00107	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Sibutramine—obesity	0.000214	0.00107	CcSEcCtD
Pazopanib—Dyspepsia—Orlistat—obesity	0.000214	0.00106	CcSEcCtD
Pazopanib—Chest pain—Bupropion—obesity	0.000214	0.00106	CcSEcCtD
Pazopanib—Myalgia—Bupropion—obesity	0.000214	0.00106	CcSEcCtD
Pazopanib—Arthralgia—Bupropion—obesity	0.000214	0.00106	CcSEcCtD
Pazopanib—Insomnia—Sibutramine—obesity	0.000213	0.00106	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000213	0.00106	CcSEcCtD
Pazopanib—Decreased appetite—Orlistat—obesity	0.000211	0.00105	CcSEcCtD
Pazopanib—Paraesthesia—Sibutramine—obesity	0.000211	0.00105	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Orlistat—obesity	0.00021	0.00104	CcSEcCtD
Pazopanib—Dyspnoea—Sibutramine—obesity	0.00021	0.00104	CcSEcCtD
Pazopanib—Photosensitivity reaction—Topiramate—obesity	0.00021	0.00104	CcSEcCtD
Pazopanib—Fatigue—Orlistat—obesity	0.00021	0.00104	CcSEcCtD
Pazopanib—Dry mouth—Bupropion—obesity	0.000209	0.00104	CcSEcCtD
Pazopanib—Somnolence—Sibutramine—obesity	0.000209	0.00104	CcSEcCtD
Pazopanib—Weight decreased—Topiramate—obesity	0.000208	0.00103	CcSEcCtD
Pazopanib—Pain—Orlistat—obesity	0.000208	0.00103	CcSEcCtD
Pazopanib—Dyspepsia—Sibutramine—obesity	0.000207	0.00103	CcSEcCtD
Pazopanib—Oedema—Bupropion—obesity	0.000205	0.00102	CcSEcCtD
Pazopanib—Infestation NOS—Topiramate—obesity	0.000205	0.00102	CcSEcCtD
Pazopanib—Infestation—Topiramate—obesity	0.000205	0.00102	CcSEcCtD
Pazopanib—Decreased appetite—Sibutramine—obesity	0.000205	0.00102	CcSEcCtD
Pazopanib—CYP1A2—digestive system—obesity	0.000204	0.00131	CbGeAlD
Pazopanib—Infection—Bupropion—obesity	0.000204	0.00101	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Sibutramine—obesity	0.000203	0.00101	CcSEcCtD
Pazopanib—ABCG2—adrenal gland—obesity	0.000202	0.0013	CbGeAlD
Pazopanib—Shock—Bupropion—obesity	0.000202	0.001	CcSEcCtD
Pazopanib—Pain—Sibutramine—obesity	0.000201	0.001	CcSEcCtD
Pazopanib—Nervous system disorder—Bupropion—obesity	0.000201	0.001	CcSEcCtD
Pazopanib—Thrombocytopenia—Bupropion—obesity	0.000201	0.000998	CcSEcCtD
Pazopanib—Stomatitis—Topiramate—obesity	0.0002	0.000993	CcSEcCtD
Pazopanib—Skin disorder—Bupropion—obesity	0.000199	0.00099	CcSEcCtD
Pazopanib—Gastrointestinal pain—Orlistat—obesity	0.000199	0.000988	CcSEcCtD
Pazopanib—Hyperhidrosis—Bupropion—obesity	0.000198	0.000986	CcSEcCtD
Pazopanib—Anorexia—Bupropion—obesity	0.000196	0.000972	CcSEcCtD
Pazopanib—Haematuria—Topiramate—obesity	0.000195	0.000971	CcSEcCtD
Pazopanib—Epistaxis—Topiramate—obesity	0.000193	0.000961	CcSEcCtD
Pazopanib—Gastrointestinal pain—Sibutramine—obesity	0.000192	0.000956	CcSEcCtD
Pazopanib—Abdominal pain—Orlistat—obesity	0.000192	0.000955	CcSEcCtD
Pazopanib—Bradycardia—Topiramate—obesity	0.000187	0.000931	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Bupropion—obesity	0.000187	0.000929	CcSEcCtD
Pazopanib—Abdominal pain—Sibutramine—obesity	0.000186	0.000924	CcSEcCtD
Pazopanib—Insomnia—Bupropion—obesity	0.000186	0.000922	CcSEcCtD
Pazopanib—Haemoglobin—Topiramate—obesity	0.000185	0.000919	CcSEcCtD
Pazopanib—Paraesthesia—Bupropion—obesity	0.000184	0.000915	CcSEcCtD
Pazopanib—Haemorrhage—Topiramate—obesity	0.000184	0.000914	CcSEcCtD
Pazopanib—Hypoaesthesia—Topiramate—obesity	0.000183	0.00091	CcSEcCtD
Pazopanib—Dyspnoea—Bupropion—obesity	0.000183	0.000909	CcSEcCtD
Pazopanib—Somnolence—Bupropion—obesity	0.000182	0.000906	CcSEcCtD
Pazopanib—Urinary tract disorder—Topiramate—obesity	0.000182	0.000903	CcSEcCtD
Pazopanib—Oedema peripheral—Topiramate—obesity	0.000181	0.000901	CcSEcCtD
Pazopanib—Connective tissue disorder—Topiramate—obesity	0.000181	0.000898	CcSEcCtD
Pazopanib—Dyspepsia—Bupropion—obesity	0.000181	0.000897	CcSEcCtD
Pazopanib—CYP2C8—endocrine gland—obesity	0.00018	0.00116	CbGeAlD
Pazopanib—Urethral disorder—Topiramate—obesity	0.00018	0.000896	CcSEcCtD
Pazopanib—Decreased appetite—Bupropion—obesity	0.000178	0.000886	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Bupropion—obesity	0.000177	0.00088	CcSEcCtD
Pazopanib—Fatigue—Bupropion—obesity	0.000177	0.000879	CcSEcCtD
Pazopanib—Pain—Bupropion—obesity	0.000175	0.000872	CcSEcCtD
Pazopanib—Asthenia—Orlistat—obesity	0.000175	0.000867	CcSEcCtD
Pazopanib—ABCB1—islet of Langerhans—obesity	0.000174	0.00112	CbGeAlD
Pazopanib—Pruritus—Orlistat—obesity	0.000172	0.000855	CcSEcCtD
Pazopanib—Eye disorder—Topiramate—obesity	0.000172	0.000854	CcSEcCtD
Pazopanib—Flushing—Topiramate—obesity	0.000171	0.000848	CcSEcCtD
Pazopanib—Cardiac disorder—Topiramate—obesity	0.000171	0.000848	CcSEcCtD
Pazopanib—Asthenia—Sibutramine—obesity	0.000169	0.000839	CcSEcCtD
Pazopanib—CYP1A2—endocrine gland—obesity	0.000169	0.00108	CbGeAlD
Pazopanib—Gastrointestinal pain—Bupropion—obesity	0.000168	0.000834	CcSEcCtD
Pazopanib—Angiopathy—Topiramate—obesity	0.000167	0.000829	CcSEcCtD
Pazopanib—Pruritus—Sibutramine—obesity	0.000167	0.000827	CcSEcCtD
Pazopanib—Diarrhoea—Orlistat—obesity	0.000166	0.000827	CcSEcCtD
Pazopanib—Mediastinal disorder—Topiramate—obesity	0.000166	0.000824	CcSEcCtD
Pazopanib—Chills—Topiramate—obesity	0.000165	0.00082	CcSEcCtD
Pazopanib—ABCB1—respiratory system—obesity	0.000165	0.00106	CbGeAlD
Pazopanib—CYP2C8—liver—obesity	0.000163	0.00104	CbGeAlD
Pazopanib—Alopecia—Topiramate—obesity	0.000163	0.000808	CcSEcCtD
Pazopanib—Abdominal pain—Bupropion—obesity	0.000162	0.000806	CcSEcCtD
Pazopanib—Mental disorder—Topiramate—obesity	0.000161	0.000801	CcSEcCtD
Pazopanib—Diarrhoea—Sibutramine—obesity	0.000161	0.0008	CcSEcCtD
Pazopanib—Dizziness—Orlistat—obesity	0.000161	0.000799	CcSEcCtD
Pazopanib—Malnutrition—Topiramate—obesity	0.00016	0.000796	CcSEcCtD
Pazopanib—Erythema—Topiramate—obesity	0.00016	0.000796	CcSEcCtD
Pazopanib—ABCG2—liver—obesity	0.000158	0.00101	CbGeAlD
Pazopanib—Flatulence—Topiramate—obesity	0.000158	0.000784	CcSEcCtD
Pazopanib—Dysgeusia—Topiramate—obesity	0.000157	0.000779	CcSEcCtD
Pazopanib—Dizziness—Sibutramine—obesity	0.000156	0.000773	CcSEcCtD
Pazopanib—Vomiting—Orlistat—obesity	0.000155	0.000768	CcSEcCtD
Pazopanib—Muscle spasms—Topiramate—obesity	0.000154	0.000765	CcSEcCtD
Pazopanib—Rash—Orlistat—obesity	0.000153	0.000762	CcSEcCtD
Pazopanib—Dermatitis—Orlistat—obesity	0.000153	0.000761	CcSEcCtD
Pazopanib—Headache—Orlistat—obesity	0.000152	0.000757	CcSEcCtD
Pazopanib—CYP1A2—liver—obesity	0.000152	0.000976	CbGeAlD
Pazopanib—Vision blurred—Topiramate—obesity	0.000151	0.00075	CcSEcCtD
Pazopanib—Vomiting—Sibutramine—obesity	0.00015	0.000744	CcSEcCtD
Pazopanib—Rash—Sibutramine—obesity	0.000148	0.000737	CcSEcCtD
Pazopanib—Dermatitis—Sibutramine—obesity	0.000148	0.000737	CcSEcCtD
Pazopanib—Anaemia—Topiramate—obesity	0.000148	0.000736	CcSEcCtD
Pazopanib—CYP3A4—digestive system—obesity	0.000148	0.000949	CbGeAlD
Pazopanib—Headache—Sibutramine—obesity	0.000147	0.000733	CcSEcCtD
Pazopanib—Asthenia—Bupropion—obesity	0.000147	0.000731	CcSEcCtD
Pazopanib—CYP2D6—digestive system—obesity	0.000146	0.000933	CbGeAlD
Pazopanib—Pruritus—Bupropion—obesity	0.000145	0.000721	CcSEcCtD
Pazopanib—Nausea—Orlistat—obesity	0.000144	0.000718	CcSEcCtD
Pazopanib—Syncope—Topiramate—obesity	0.000144	0.000714	CcSEcCtD
Pazopanib—Leukopenia—Topiramate—obesity	0.000143	0.000712	CcSEcCtD
Pazopanib—Loss of consciousness—Topiramate—obesity	0.000141	0.000699	CcSEcCtD
Pazopanib—Diarrhoea—Bupropion—obesity	0.00014	0.000698	CcSEcCtD
Pazopanib—Nausea—Sibutramine—obesity	0.00014	0.000695	CcSEcCtD
Pazopanib—Cough—Topiramate—obesity	0.00014	0.000694	CcSEcCtD
Pazopanib—Hypertension—Topiramate—obesity	0.000138	0.000687	CcSEcCtD
Pazopanib—ABCB1—adrenal cortex—obesity	0.000138	0.000886	CbGeAlD
Pazopanib—Chest pain—Topiramate—obesity	0.000136	0.000678	CcSEcCtD
Pazopanib—Arthralgia—Topiramate—obesity	0.000136	0.000678	CcSEcCtD
Pazopanib—Myalgia—Topiramate—obesity	0.000136	0.000678	CcSEcCtD
Pazopanib—Dizziness—Bupropion—obesity	0.000136	0.000674	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000135	0.000673	CcSEcCtD
Pazopanib—Dry mouth—Topiramate—obesity	0.000133	0.000663	CcSEcCtD
Pazopanib—Oedema—Topiramate—obesity	0.000131	0.000649	CcSEcCtD
Pazopanib—Vomiting—Bupropion—obesity	0.00013	0.000648	CcSEcCtD
Pazopanib—Infection—Topiramate—obesity	0.00013	0.000645	CcSEcCtD
Pazopanib—Rash—Bupropion—obesity	0.000129	0.000643	CcSEcCtD
Pazopanib—Dermatitis—Bupropion—obesity	0.000129	0.000642	CcSEcCtD
Pazopanib—Shock—Topiramate—obesity	0.000129	0.000639	CcSEcCtD
Pazopanib—Headache—Bupropion—obesity	0.000129	0.000639	CcSEcCtD
Pazopanib—Nervous system disorder—Topiramate—obesity	0.000128	0.000637	CcSEcCtD
Pazopanib—Thrombocytopenia—Topiramate—obesity	0.000128	0.000636	CcSEcCtD
Pazopanib—Skin disorder—Topiramate—obesity	0.000127	0.000631	CcSEcCtD
Pazopanib—Hyperhidrosis—Topiramate—obesity	0.000126	0.000628	CcSEcCtD
Pazopanib—ABCB1—cardiovascular system—obesity	0.000126	0.000809	CbGeAlD
Pazopanib—Anorexia—Topiramate—obesity	0.000125	0.000619	CcSEcCtD
Pazopanib—CYP3A4—endocrine gland—obesity	0.000122	0.000784	CbGeAlD
Pazopanib—Nausea—Bupropion—obesity	0.000122	0.000606	CcSEcCtD
Pazopanib—CYP2D6—endocrine gland—obesity	0.00012	0.000771	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Topiramate—obesity	0.000119	0.000592	CcSEcCtD
Pazopanib—Insomnia—Topiramate—obesity	0.000118	0.000587	CcSEcCtD
Pazopanib—Paraesthesia—Topiramate—obesity	0.000117	0.000583	CcSEcCtD
Pazopanib—Dyspnoea—Topiramate—obesity	0.000117	0.000579	CcSEcCtD
Pazopanib—Somnolence—Topiramate—obesity	0.000116	0.000577	CcSEcCtD
Pazopanib—Dyspepsia—Topiramate—obesity	0.000115	0.000572	CcSEcCtD
Pazopanib—Decreased appetite—Topiramate—obesity	0.000114	0.000565	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Topiramate—obesity	0.000113	0.000561	CcSEcCtD
Pazopanib—Fatigue—Topiramate—obesity	0.000113	0.00056	CcSEcCtD
Pazopanib—Pain—Topiramate—obesity	0.000112	0.000555	CcSEcCtD
Pazopanib—ABCB1—pituitary gland—obesity	0.000112	0.000716	CbGeAlD
Pazopanib—ABCB1—adipose tissue—obesity	0.000111	0.000713	CbGeAlD
Pazopanib—CYP3A4—liver—obesity	0.00011	0.000707	CbGeAlD
Pazopanib—CYP2D6—liver—obesity	0.000108	0.000695	CbGeAlD
Pazopanib—Gastrointestinal pain—Topiramate—obesity	0.000107	0.000531	CcSEcCtD
Pazopanib—ABCB1—digestive system—obesity	0.000105	0.000671	CbGeAlD
Pazopanib—Abdominal pain—Topiramate—obesity	0.000103	0.000513	CcSEcCtD
Pazopanib—ABCB1—adrenal gland—obesity	9.97e-05	0.00064	CbGeAlD
Pazopanib—Asthenia—Topiramate—obesity	9.38e-05	0.000466	CcSEcCtD
Pazopanib—Pruritus—Topiramate—obesity	9.25e-05	0.00046	CcSEcCtD
Pazopanib—Diarrhoea—Topiramate—obesity	8.95e-05	0.000444	CcSEcCtD
Pazopanib—ABCB1—endocrine gland—obesity	8.65e-05	0.000555	CbGeAlD
Pazopanib—Dizziness—Topiramate—obesity	8.65e-05	0.000429	CcSEcCtD
Pazopanib—Vomiting—Topiramate—obesity	8.31e-05	0.000413	CcSEcCtD
Pazopanib—Rash—Topiramate—obesity	8.24e-05	0.00041	CcSEcCtD
Pazopanib—Dermatitis—Topiramate—obesity	8.24e-05	0.000409	CcSEcCtD
Pazopanib—Headache—Topiramate—obesity	8.19e-05	0.000407	CcSEcCtD
Pazopanib—ABCB1—liver—obesity	7.8e-05	0.0005	CbGeAlD
Pazopanib—Nausea—Topiramate—obesity	7.77e-05	0.000386	CcSEcCtD
Pazopanib—LCK—Signaling Pathways—SERPINE1—obesity	1.58e-06	5.99e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—COMT—obesity	1.58e-06	5.98e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOB—obesity	1.58e-06	5.97e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—STAT3—obesity	1.57e-06	5.96e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—obesity	1.57e-06	5.94e-06	CbGpPWpGaD
Pazopanib—KIT—Immune System—AKT1—obesity	1.57e-06	5.94e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.57e-06	5.92e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CPT1A—obesity	1.56e-06	5.91e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GNB3—obesity	1.56e-06	5.9e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARGC1A—obesity	1.56e-06	5.9e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MTHFR—obesity	1.56e-06	5.89e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HMOX1—obesity	1.55e-06	5.87e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.55e-06	5.87e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TYK2—obesity	1.54e-06	5.82e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—STAT3—obesity	1.54e-06	5.82e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GCG—obesity	1.53e-06	5.8e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC2A4—obesity	1.53e-06	5.8e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NAMPT—obesity	1.53e-06	5.79e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PIK3CA—obesity	1.53e-06	5.78e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARA—obesity	1.53e-06	5.78e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RHOA—obesity	1.53e-06	5.78e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GCK—obesity	1.52e-06	5.76e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—LIPC—obesity	1.52e-06	5.76e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GNAS—obesity	1.52e-06	5.75e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYCS—obesity	1.51e-06	5.72e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PIK3CA—obesity	1.51e-06	5.72e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOC3—obesity	1.51e-06	5.72e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOS3—obesity	1.51e-06	5.72e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3R1—obesity	1.51e-06	5.72e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—obesity	1.51e-06	5.71e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—LPL—obesity	1.51e-06	5.7e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKT1—obesity	1.5e-06	5.68e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—STAT3—obesity	1.49e-06	5.65e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—obesity	1.49e-06	5.64e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—STAT3—obesity	1.49e-06	5.64e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MYC—obesity	1.49e-06	5.64e-06	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—AKT1—obesity	1.49e-06	5.64e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOB—obesity	1.49e-06	5.63e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—obesity	1.49e-06	5.63e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFB1—obesity	1.49e-06	5.62e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—AKT1—obesity	1.49e-06	5.62e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT1—obesity	1.48e-06	5.62e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GGT1—obesity	1.48e-06	5.62e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AGT—obesity	1.48e-06	5.6e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—obesity	1.48e-06	5.59e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKT1—obesity	1.48e-06	5.58e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GPX1—obesity	1.47e-06	5.56e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAPK8—obesity	1.47e-06	5.56e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CETP—obesity	1.47e-06	5.55e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MYC—obesity	1.46e-06	5.54e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NCOA1—obesity	1.46e-06	5.53e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFB1—obesity	1.46e-06	5.52e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—obesity	1.46e-06	5.51e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SDC1—obesity	1.45e-06	5.49e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—obesity	1.45e-06	5.49e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOE—obesity	1.45e-06	5.49e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—AKT1—obesity	1.45e-06	5.48e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP19A1—obesity	1.44e-06	5.45e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—STK11—obesity	1.44e-06	5.45e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAPK8—obesity	1.44e-06	5.44e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAV1—obesity	1.44e-06	5.43e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOA1—obesity	1.43e-06	5.42e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CD36—obesity	1.43e-06	5.42e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—MYC—obesity	1.43e-06	5.41e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKR1C3—obesity	1.43e-06	5.4e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFB1—obesity	1.43e-06	5.4e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—obesity	1.42e-06	5.37e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—LPL—obesity	1.42e-06	5.37e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—obesity	1.42e-06	5.37e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SCARB1—obesity	1.41e-06	5.32e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MTOR—obesity	1.39e-06	5.28e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CB—obesity	1.39e-06	5.28e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MYC—obesity	1.39e-06	5.25e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GPX1—obesity	1.39e-06	5.24e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFB1—obesity	1.39e-06	5.24e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MYC—obesity	1.39e-06	5.24e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFB1—obesity	1.38e-06	5.23e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKT1—obesity	1.38e-06	5.2e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.37e-06	5.19e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKT1—obesity	1.37e-06	5.19e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SREBF1—obesity	1.36e-06	5.16e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MTHFR—obesity	1.36e-06	5.13e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—obesity	1.35e-06	5.12e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CD36—obesity	1.35e-06	5.1e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKT1—obesity	1.34e-06	5.08e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—STAT3—obesity	1.34e-06	5.08e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—COMT—obesity	1.34e-06	5.07e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—obesity	1.34e-06	5.07e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—AKT1—obesity	1.34e-06	5.06e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARA—obesity	1.33e-06	5.04e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT2—obesity	1.33e-06	5.02e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GNB3—obesity	1.32e-06	5e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARGC1A—obesity	1.32e-06	5e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HMOX1—obesity	1.32e-06	4.98e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—PIK3CA—obesity	1.31e-06	4.97e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—STAT3—obesity	1.31e-06	4.97e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—AKT1—obesity	1.31e-06	4.96e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKT1—obesity	1.31e-06	4.95e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CG—obesity	1.31e-06	4.95e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—FASN—obesity	1.3e-06	4.91e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—BCHE—obesity	1.29e-06	4.89e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AGT—obesity	1.29e-06	4.88e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GNAS—obesity	1.29e-06	4.87e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MTHFR—obesity	1.28e-06	4.84e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PIK3CA—obesity	1.26e-06	4.79e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOE—obesity	1.26e-06	4.78e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARG—obesity	1.26e-06	4.78e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOB—obesity	1.26e-06	4.77e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARA—obesity	1.25e-06	4.75e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAV1—obesity	1.25e-06	4.73e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOA1—obesity	1.25e-06	4.72e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKT1—obesity	1.25e-06	4.72e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2E1—obesity	1.25e-06	4.72e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MYC—obesity	1.25e-06	4.72e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—obesity	1.25e-06	4.71e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFB1—obesity	1.24e-06	4.71e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PIK3CA—obesity	1.24e-06	4.7e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—INS—obesity	1.24e-06	4.69e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKT1—obesity	1.24e-06	4.68e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NQO1—obesity	1.23e-06	4.67e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MYC—obesity	1.22e-06	4.62e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFB1—obesity	1.22e-06	4.61e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AGT—obesity	1.21e-06	4.6e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—PIK3CA—obesity	1.21e-06	4.59e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—obesity	1.21e-06	4.59e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—LPL—obesity	1.2e-06	4.55e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOE—obesity	1.19e-06	4.5e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GCG—obesity	1.18e-06	4.48e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC2A4—obesity	1.18e-06	4.48e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAV1—obesity	1.18e-06	4.46e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PIK3CA—obesity	1.18e-06	4.46e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAPK8—obesity	1.18e-06	4.46e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOA1—obesity	1.18e-06	4.45e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PIK3CA—obesity	1.18e-06	4.45e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GPX1—obesity	1.17e-06	4.44e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYCS—obesity	1.17e-06	4.42e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—obesity	1.16e-06	4.41e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PIK3CA—obesity	1.16e-06	4.39e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CD—obesity	1.15e-06	4.35e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT1—obesity	1.15e-06	4.34e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GGT1—obesity	1.15e-06	4.34e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CD36—obesity	1.14e-06	4.32e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CG—obesity	1.14e-06	4.31e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—obesity	1.14e-06	4.3e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NCOA1—obesity	1.13e-06	4.27e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—obesity	1.12e-06	4.24e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—STK11—obesity	1.11e-06	4.21e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP19A1—obesity	1.11e-06	4.21e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARG—obesity	1.1e-06	4.16e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—obesity	1.1e-06	4.16e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3R1—obesity	1.09e-06	4.11e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NOS3—obesity	1.09e-06	4.11e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—obesity	1.09e-06	4.11e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MTHFR—obesity	1.08e-06	4.1e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—INS—obesity	1.08e-06	4.08e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—STAT3—obesity	1.08e-06	4.08e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—obesity	1.07e-06	4.07e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CG—obesity	1.07e-06	4.06e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—AKT1—obesity	1.07e-06	4.06e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PIK3CA—obesity	1.06e-06	4.02e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARA—obesity	1.06e-06	4.02e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PIK3CA—obesity	1.06e-06	4.01e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—obesity	1.04e-06	3.95e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—obesity	1.04e-06	3.94e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PIK3CA—obesity	1.04e-06	3.92e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARG—obesity	1.04e-06	3.92e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—COMT—obesity	1.03e-06	3.91e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKT1—obesity	1.03e-06	3.91e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AGT—obesity	1.03e-06	3.89e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—obesity	1.02e-06	3.87e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARGC1A—obesity	1.02e-06	3.86e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GNB3—obesity	1.02e-06	3.86e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—INS—obesity	1.02e-06	3.85e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HMOX1—obesity	1.02e-06	3.84e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKT1—obesity	1.01e-06	3.84e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOE—obesity	1.01e-06	3.82e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CB—obesity	1e-06	3.79e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CD—obesity	1e-06	3.79e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MYC—obesity	1e-06	3.79e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAV1—obesity	9.99e-07	3.78e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFB1—obesity	9.99e-07	3.78e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOA1—obesity	9.97e-07	3.77e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—obesity	9.93e-07	3.76e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GNAS—obesity	9.93e-07	3.76e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—AKT1—obesity	9.92e-07	3.75e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—obesity	9.89e-07	3.74e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PIK3CA—obesity	9.85e-07	3.73e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOB—obesity	9.72e-07	3.68e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKT1—obesity	9.63e-07	3.64e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKT1—obesity	9.61e-07	3.63e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.55e-07	3.61e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AKT1—obesity	9.48e-07	3.59e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NOS3—obesity	9.46e-07	3.58e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3R1—obesity	9.46e-07	3.58e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CD—obesity	9.44e-07	3.57e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—obesity	9.38e-07	3.55e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—obesity	9.32e-07	3.53e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—LPL—obesity	9.28e-07	3.51e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—obesity	9.18e-07	3.47e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CG—obesity	9.1e-07	3.44e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GPX1—obesity	9.06e-07	3.43e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3R1—obesity	8.92e-07	3.37e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NOS3—obesity	8.92e-07	3.37e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CD36—obesity	8.82e-07	3.34e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARG—obesity	8.78e-07	3.32e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CB—obesity	8.73e-07	3.3e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AKT1—obesity	8.69e-07	3.29e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—obesity	8.66e-07	3.28e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—obesity	8.66e-07	3.27e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKT1—obesity	8.65e-07	3.27e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—INS—obesity	8.61e-07	3.26e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CA—obesity	8.5e-07	3.22e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKT1—obesity	8.47e-07	3.21e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MTHFR—obesity	8.36e-07	3.16e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CB—obesity	8.23e-07	3.11e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARA—obesity	8.2e-07	3.1e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—obesity	8.16e-07	3.09e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AKT1—obesity	8.05e-07	3.04e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CD—obesity	8e-07	3.03e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AGT—obesity	7.94e-07	3e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—obesity	7.9e-07	2.99e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOE—obesity	7.78e-07	2.94e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAV1—obesity	7.71e-07	2.92e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOA1—obesity	7.69e-07	2.91e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3R1—obesity	7.55e-07	2.86e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NOS3—obesity	7.55e-07	2.86e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—obesity	7.53e-07	2.85e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CG—obesity	7.02e-07	2.66e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CB—obesity	6.97e-07	2.64e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT1—obesity	6.94e-07	2.63e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—obesity	6.91e-07	2.61e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARG—obesity	6.78e-07	2.56e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—obesity	6.69e-07	2.53e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—INS—obesity	6.65e-07	2.52e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CD—obesity	6.17e-07	2.34e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CA—obesity	6.11e-07	2.31e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—obesity	6.1e-07	2.31e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3R1—obesity	5.83e-07	2.21e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NOS3—obesity	5.83e-07	2.21e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CB—obesity	5.38e-07	2.04e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—obesity	5.33e-07	2.02e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CA—obesity	5.32e-07	2.01e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CA—obesity	5.02e-07	1.9e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AKT1—obesity	4.99e-07	1.89e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AKT1—obesity	4.35e-07	1.65e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CA—obesity	4.25e-07	1.61e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKT1—obesity	4.1e-07	1.55e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKT1—obesity	3.47e-07	1.31e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CA—obesity	3.28e-07	1.24e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKT1—obesity	2.68e-07	1.01e-06	CbGpPWpGaD
